{
    "title": "109_hr3423",
    "content": "The Act may be cited as the \"Medical Device User Fee Stabilization Act of 2005\" and includes amendments to the Federal Food, Drug, and Cosmetic Act. The Federal Food, Drug, and Cosmetic Act is amended regarding device user fees, specifically in subsections (b) and (c). Changes include adjusting fees for the next fiscal year and publishing them in the Federal Register. The Federal Food, Drug, and Cosmetic Act is amended to adjust device user fees for fiscal years 2006 and 2007, with changes including publishing fees in the Federal Register and using unobligated carryover balances from previous years to ensure sufficient fee revenues. The Secretary can use unobligated carryover balances from previous fiscal years to maintain fee revenues, with a requirement to notify Congress before doing so. In subsection (d), the definition of 'small business' is revised to include entities with $30,000,000 or less in gross receipts or sales. Additionally, the threshold for this definition is increased to $100,000,000. In subsection (d), the definition of 'small business' is revised to include entities with $30,000,000 or less in gross receipts or sales, with the threshold increased to $100,000,000. In subsection (e)(2)(A) and (g)(1), the amount is adjusted from $30,000,000 to $100,000,000. For fiscal year 2005, if the appropriated amount, excluding fees, is more than 1% less than $205,720,000 multiplied by the adjustment factor, certain conditions apply. For fiscal year 2005, the appropriated amount, excluding fees, must be more than 1% less than $205,720,000 multiplied by the adjustment factor. This involves striking \"2003 through\" and inserting \"2005 and\", as well as inserting \"more than 1 percent\" after \"years, is\". In subsection (h)(3), amendments are made to subparagraphs (C), (D), and (E) for fiscal years 2006 and 2007. Additionally, changes are made to section 103 of the Medical Device User Fee and Modernization Act of 2002 regarding annual reports. The Modernization Act of 2002 is amended to include additional information for fiscal years 2006 and 2007, requiring a report to include details on different types of applications and notifications, fees paid by businesses with varying gross receipts, and a certification by the Secretary on appropriations for FDA expenses related to devices. The Modernization Act of 2002 is amended to require a certification by the Secretary on FDA expenses for devices not related to the review process. Additionally, the section on misbranded devices is amended to include requirements for reprocessed single-use devices. The Cosmetic Act is amended to require reprocessed single-use devices to bear the manufacturer's name, abbreviation, or symbol. Reprocessed devices without this information may use a detachable label on the packaging. Guidance on these requirements must be provided within 180 days. The Secretary of Health and Human Services will issue guidance within 180 days to determine when the manufacturer's name, abbreviation, or symbol on reprocessed single-use devices is not considered prominent and conspicuous. The Effective Date for the Medical Device User Fee Stabilization Act of 2005 is determined based on when the original device bears the manufacturer's name, abbreviation, or symbol, 12 months after enactment or later. The Effective Date for the Medical Device User Fee Stabilization Act of 2005 is determined based on when the original device bears the manufacturer's name, abbreviation, or symbol, 12 months after enactment or later. The act applies only to reprocessed devices introduced in interstate commerce after the effective date. The curr_chunk is about the roles of the Speaker of the House of Representatives and the Vice President of the United States as President of the Senate."
}